Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 16 | 2024 | 1849 | 3.340 |
Why?
|
| Hypoglossal Nerve | 11 | 2024 | 100 | 3.240 |
Why?
|
| Electric Stimulation Therapy | 7 | 2024 | 605 | 2.840 |
Why?
|
| Paranasal Sinuses | 2 | 2017 | 265 | 0.940 |
Why?
|
| Endoscopy | 5 | 2024 | 1838 | 0.920 |
Why?
|
| Snoring | 1 | 2023 | 206 | 0.760 |
Why?
|
| Polysomnography | 7 | 2024 | 1803 | 0.740 |
Why?
|
| Middle Ear Ventilation | 2 | 2018 | 97 | 0.700 |
Why?
|
| Otitis Media with Effusion | 2 | 2018 | 114 | 0.660 |
Why?
|
| Numismatics | 1 | 2018 | 17 | 0.640 |
Why?
|
| Epistaxis | 1 | 2019 | 111 | 0.620 |
Why?
|
| Oximetry | 1 | 2020 | 460 | 0.590 |
Why?
|
| Mastoiditis | 1 | 2016 | 37 | 0.560 |
Why?
|
| Mastoid | 1 | 2016 | 95 | 0.550 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2017 | 121 | 0.540 |
Why?
|
| Neck Dissection | 1 | 2018 | 200 | 0.540 |
Why?
|
| Parotid Neoplasms | 1 | 2018 | 156 | 0.540 |
Why?
|
| Airway Obstruction | 1 | 2021 | 655 | 0.520 |
Why?
|
| Perineum | 1 | 2017 | 209 | 0.510 |
Why?
|
| Facial Nerve | 1 | 2018 | 277 | 0.510 |
Why?
|
| Ear Auricle | 1 | 2015 | 31 | 0.500 |
Why?
|
| Skull Base | 1 | 2018 | 291 | 0.500 |
Why?
|
| Otitis Media | 1 | 2017 | 285 | 0.500 |
Why?
|
| Ear Neoplasms | 1 | 2015 | 118 | 0.480 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2022 | 971 | 0.470 |
Why?
|
| Foreign Bodies | 1 | 2018 | 392 | 0.460 |
Why?
|
| Facial Paralysis | 1 | 2018 | 345 | 0.450 |
Why?
|
| Income | 1 | 2022 | 1864 | 0.450 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 455 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 2 | 2017 | 2868 | 0.420 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.410 |
Why?
|
| Esophagus | 1 | 2018 | 1020 | 0.410 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 1108 | 0.400 |
Why?
|
| Sinusitis | 4 | 2016 | 989 | 0.400 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4005 | 0.380 |
Why?
|
| Neck | 1 | 2016 | 724 | 0.380 |
Why?
|
| Sleep | 7 | 2024 | 4687 | 0.360 |
Why?
|
| Head | 1 | 2016 | 911 | 0.350 |
Why?
|
| Intensive Care Units | 3 | 2017 | 3697 | 0.330 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 1394 | 0.330 |
Why?
|
| Mortality | 1 | 2020 | 2882 | 0.320 |
Why?
|
| Health Expenditures | 1 | 2021 | 2335 | 0.320 |
Why?
|
| Reoperation | 2 | 2024 | 4256 | 0.320 |
Why?
|
| Epiglottis | 2 | 2024 | 81 | 0.290 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15438 | 0.270 |
Why?
|
| Pneumonia | 1 | 2017 | 2122 | 0.260 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2016 | 167 | 0.250 |
Why?
|
| Pennsylvania | 2 | 2016 | 610 | 0.250 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1395 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 20351 | 0.240 |
Why?
|
| Middle Aged | 19 | 2024 | 217039 | 0.240 |
Why?
|
| Palate | 2 | 2024 | 123 | 0.240 |
Why?
|
| Implantable Neurostimulators | 2 | 2024 | 72 | 0.230 |
Why?
|
| Oropharynx | 2 | 2023 | 130 | 0.230 |
Why?
|
| Female | 26 | 2024 | 386085 | 0.220 |
Why?
|
| Male | 26 | 2024 | 354908 | 0.220 |
Why?
|
| Aryldialkylphosphatase | 1 | 2022 | 63 | 0.210 |
Why?
|
| Deglutition | 1 | 2024 | 200 | 0.210 |
Why?
|
| Humans | 41 | 2024 | 752411 | 0.210 |
Why?
|
| Adult | 20 | 2024 | 216927 | 0.200 |
Why?
|
| Tongue | 2 | 2024 | 403 | 0.190 |
Why?
|
| Preoperative Period | 2 | 2021 | 549 | 0.180 |
Why?
|
| Models, Biological | 1 | 2017 | 9449 | 0.180 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 255 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 79133 | 0.170 |
Why?
|
| Aged | 12 | 2024 | 166585 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35932 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3585 | 0.160 |
Why?
|
| Endopeptidases | 1 | 2023 | 772 | 0.160 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 1319 | 0.160 |
Why?
|
| Treatment Outcome | 8 | 2024 | 64250 | 0.160 |
Why?
|
| Immunization | 1 | 2023 | 1218 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 58299 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2023 | 53809 | 0.150 |
Why?
|
| Recurrence | 3 | 2019 | 8420 | 0.150 |
Why?
|
| Certification | 1 | 2021 | 420 | 0.150 |
Why?
|
| Prevalence | 3 | 2020 | 15508 | 0.140 |
Why?
|
| Nasal Polyps | 3 | 2013 | 396 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1674 | 0.140 |
Why?
|
| Demography | 1 | 2021 | 1638 | 0.140 |
Why?
|
| Employment | 1 | 2022 | 1112 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 57632 | 0.120 |
Why?
|
| Neurites | 1 | 2017 | 384 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2022 | 759 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1573 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8539 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2016 | 336 | 0.120 |
Why?
|
| Incidence | 3 | 2017 | 21157 | 0.120 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 521 | 0.120 |
Why?
|
| Otolaryngology | 1 | 2021 | 676 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 4702 | 0.110 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2018 | 449 | 0.110 |
Why?
|
| Adolescent | 7 | 2020 | 86766 | 0.110 |
Why?
|
| United States | 5 | 2022 | 71438 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1697 | 0.110 |
Why?
|
| Length of Stay | 2 | 2016 | 6372 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 1150 | 0.110 |
Why?
|
| Counseling | 1 | 2021 | 1541 | 0.110 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15680 | 0.110 |
Why?
|
| Infant | 4 | 2018 | 35675 | 0.100 |
Why?
|
| Observer Variation | 1 | 2018 | 2583 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 470 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2018 | 41660 | 0.100 |
Why?
|
| Age Factors | 3 | 2018 | 18298 | 0.100 |
Why?
|
| Risk Factors | 5 | 2023 | 73425 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3474 | 0.090 |
Why?
|
| Vaccination | 1 | 2023 | 3322 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2017 | 3582 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 29337 | 0.090 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2013 | 203 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2666 | 0.080 |
Why?
|
| Interleukin-9 | 1 | 2009 | 58 | 0.080 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2024 | 573 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4239 | 0.080 |
Why?
|
| Thyroid Neoplasms | 1 | 2022 | 2309 | 0.080 |
Why?
|
| Eosinophils | 1 | 2013 | 945 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2021 | 3209 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2024 | 12138 | 0.080 |
Why?
|
| Rhinitis | 2 | 2013 | 746 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2020 | 9701 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2018 | 3463 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3117 | 0.070 |
Why?
|
| Child | 5 | 2022 | 79004 | 0.070 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6780 | 0.070 |
Why?
|
| Radiography | 1 | 2018 | 6965 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7212 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2011 | 556 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 596 | 0.070 |
Why?
|
| Comorbidity | 1 | 2020 | 10475 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12455 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2008 | 752 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2013 | 3122 | 0.060 |
Why?
|
| Critical Care | 1 | 2017 | 2677 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 1945 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12745 | 0.060 |
Why?
|
| Palate, Hard | 1 | 2023 | 58 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5279 | 0.060 |
Why?
|
| Palate, Soft | 1 | 2023 | 100 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14588 | 0.050 |
Why?
|
| Biopsy | 1 | 2015 | 6743 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3798 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12796 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1163 | 0.050 |
Why?
|
| Decision Making | 1 | 2016 | 3888 | 0.050 |
Why?
|
| Pharynx | 1 | 2024 | 429 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3341 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2009 | 2471 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16737 | 0.040 |
Why?
|
| Cytokines | 2 | 2013 | 7235 | 0.040 |
Why?
|
| Germinal Center | 1 | 2023 | 382 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2024 | 451 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2024 | 947 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2023 | 474 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12901 | 0.040 |
Why?
|
| Larynx | 1 | 2024 | 491 | 0.040 |
Why?
|
| Specialty Boards | 1 | 2021 | 228 | 0.040 |
Why?
|
| Device Removal | 1 | 2024 | 635 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25539 | 0.040 |
Why?
|
| Video Recording | 1 | 2024 | 943 | 0.040 |
Why?
|
| Monocytes | 1 | 2008 | 2556 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2024 | 617 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4571 | 0.040 |
Why?
|
| Antigens | 1 | 2023 | 1439 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 39846 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4279 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25919 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13154 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7576 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 80550 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 2035 | 0.030 |
Why?
|
| Parotid Gland | 1 | 2013 | 174 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2013 | 233 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 11884 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 289 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10035 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 166811 | 0.020 |
Why?
|
| Logistic Models | 1 | 2024 | 13277 | 0.020 |
Why?
|
| Cough | 1 | 2013 | 595 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 452 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 887 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 1806 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15647 | 0.020 |
Why?
|
| Immunomagnetic Separation | 1 | 2008 | 79 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 728 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5782 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 1290 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 1632 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2013 | 9162 | 0.020 |
Why?
|
| Affect | 1 | 2013 | 1475 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12739 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10457 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4898 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1432 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7400 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6509 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4285 | 0.010 |
Why?
|
| Alleles | 1 | 2009 | 6879 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11008 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29706 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5412 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23788 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13405 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40980 | 0.010 |
Why?
|
| Asthma | 1 | 2013 | 6145 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 21851 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 18915 | 0.010 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_